Spinogenix

Los Angeles, CA · Founded 2016 · Privately Held (backing)

Operator of a biopharmaceutical company intended to restore the brain connections and functions lost in brain injury and neurodegenerative diseases. Spinogenix is based in Los Angeles, CA and was founded in 2016. It was valued at $335 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $27.4 million across 7 recorded rounds; the latest was a $10.6 million early-stage round in Nov 2025.

PMV mark · valuation
$335.0M
Oct 2026
Priced at
its later-stage round
Mar 2026
Total raised
$27.4M
Last round
Early Stage VC
Nov 2025

Who backs Spinogenix?

5 investors
InvestorType
United States Department of War—
University of CaliforniaOther
San Diego—
Stead Impact Ventures and Foundation—
U.S. Department of Health and Human Services—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Spinogenix investors

5 investors are on record for Spinogenix, including United States Department of War, University of California, San Diego and Stead Impact Ventures and Foundation. The early-stage round in Nov 2025 drew 5 investors.

Free account
More of Spinogenix with a free account
  • ·Watch Spinogenix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Spinogenix. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View